Patterns and perceptions of supplement use among patients with plasma cell disorders

This publication has 17 references indexed in Scilit:

• A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
  Cancer Discovery, 2025
• Integrative medicine in multiple myeloma and plasma cell disorders
  Complementary Therapies in Medicine, 2023
• Nutrition perceptions, needs and practices among patients with plasma cell disorders
  Blood Cancer Journal, 2022
• Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes
  Journal of Cancer Research and Clinical Oncology, 2021
• Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline
  JNCI: Journal of the National Cancer Institute, 2021
• Dietary Supplements Use among Adults with Cancer in the United States: A Population-Based Study
  Nutrition and Cancer, 2020
• Dietary Supplement Use among Adult Cancer Survivors in the United States
  The Journal of Nutrition, 2020
• Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double‐blind placebo‐controlled cross‐over 4g study and an open‐label 8g extension study
  American Journal of Hematology, 2012
• Ascorbic acid inhibits antitumor activity of bortezomib in vivo
  Leukemia, 2009
• Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies
  Complementary Therapies in Medicine, 2004